Article
The role of aberrant transcription factor in the progression of chronic myeloid leukemia.
Leukemia & lymphoma - 1 Aug 2008
Zhang Sujiang
Abstract excerpt
Chronic myeloid leukemia (CML) is a hematopoietic stem cell disease with distinct biological and clinical features. The Philadelphia (Ph) chromosome and BCR/ABL fusion gene is the major cytogenetic and molecular marker of CML chronic phase. However, the molecular mechanisms of disease progression are not well known. Recent studies have shown that a several of transcription factors such as AML1, C/EBPalpha, HOX...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
